SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-066931
Filing Date
2024-03-13
Accepted
2024-03-13 17:01:00
Documents
15
Period of Report
2024-03-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798971d8k.htm   iXBRL 8-K 25458
2 EX-99.1 d798971dex991.htm EX-99.1 18026
  Complete submission text file 0001193125-24-066931.txt   172652

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20240313.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20240313_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20240313_pre.xml EX-101.PRE 11275
17 EXTRACTED XBRL INSTANCE DOCUMENT d798971d8k_htm.xml XML 3685
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 24746834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)